Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/b6e9328b-597d-4628-aa8d-f31252e02a0e/

CGS

Cogstate Limited
Chart
2.90 AUD
Latest Week 2026-07-10
HealthcareHealth Information ServicesSMALL
Snapshot 2026-07-12 · 0.7w · Fresh
0.49
OS Score
1.0%
Value
99.0%
Quality
96.0%
Momentum
7/9
F-Score
0.099
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
2 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
12-1 67%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
RAM 1.72
V
Value Analysis
Cheapness relative to fundamentals
1.0%ile
P/E
48.6×
P/S
9.7×
P/B
10.3×
E/P
0.0236
FCF Yield
0.018
EBITDA/EV
0.037
SH Yield
0.014
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
99.00000000
/100 — 1=cheapest
VC2 (Trending Value)
99.00000000
/100
VC3 (Buyback)
99.00000000
/100
P/E of 48.6x is premium-priced — the market is paying up for expected growth. VC2 score of 99.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
99.0%ile
ROE
0.212
ROA
0.157
Net Margin
0.200
Op Margin
0.212
GPA
0.474
Current
3.77
F-Score
7/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.170
Earn Growth
0.882
5yr Consist
No
ROE of 21% is exceptional.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
96.0%ile
6M Return
33.0%
12M Return
76.7%
12-1 Mom
66.9%
Risk-Adj
1.72
Vol 252d
38.9%
Vol 60d
84.0%
↑ Expanding
Max DD 12M
-23.3%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 67% is very strong — a clear uptrend. Risk-adjusted momentum of 1.72 is excellent — strong returns relative to volatility. Near-term vol (84%) is expanding vs long-term (39%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.49
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 145 peers
Sector Value %ile
4.1%
Sector Quality %ile
100.0%
P/E z-score
-0.15
P/B z-score
0.21
Sector Avg OS
40.0%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
VLS Vita Life Sciences Limited 98.0% 94.0% 97.0% 88.0%
SDI SDI Limited 96.0% 86.0% 89.0% 95.0%
AGN Argenica Therapeutics Limited 93.0% 82.0% 80.0% 81.0%
BB1 BLINKLAB FPO [BB1] 93.0% 81.0% 80.0% 81.0%
RGT Argent BioPharma Limited 93.0% 81.0% 80.0% 81.0%
ALC Alcidion Group Limited 93.0% 81.0% 79.0% 81.0%
ENP Entropy Neurodynamics Limited 92.0% 80.0% 78.0% 80.0%
ECS ECS Botanics Holdings Ltd 92.0% 80.0% 79.0% 80.0%
Factor Interactions
Quality Momentum — Expensive
Strong quality (99th) and momentum (96th) but expensive (1th value). Premium priced — watch for mean reversion.
Quality at a Premium
High quality (99th) but expensive (1th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (84%) significantly exceeds 252-day (39%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
18.3% avg (7 factors)
Quality
A
82.0% avg (6 factors)
Momentum
A
86.7% avg (4 factors)
Risk
C
51.9% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends6 snapshots
Factor Persistence6 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.490—0—
Value %ile0.010—6—
Quality %ile0.990—6—
Momentum %ile0.960—6—
F-Score7.000—6—
Confidence0.470—0—
Volatility0.389—0—
Value Lens2021-07-13 → 2026-07-12
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
48.56
Earnings Yield (E/P)
0.0236
Price / Sales
9.70
Price / Book
10.29
FCF Yield
1.8%
EBITDA / EV
3.7%
Sales Yield (1/P·S)
0.1110
Shareholder Yield
Div + net buyback / mktcap
1.4%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
21.2%
Return on Assets
15.7%
Net Margin
20.0%
Operating Margin
21.2%
Gross Profit / Assets
Novy-Marx GPA
47.4%
Current Ratio
3.77
External Financing
Net issuance — lower=better
0.092
MomentumPrice trend strength over different horizons
6M Return
33.0%
12M Return
76.7%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
66.9%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
1.72
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
17.0%
Earnings Growth (YoY)
88.2%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
7
Dividend Yield
0.7%
Buyback Yield
0.7%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
99
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
99
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
99
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity